低出生体重增加儿童非酒精性脂肪性肝病严重脂肪变性的可能性
该研究纳入288例经活检证实非酒精性脂肪性肝病(NAFLD)的意大利超重/肥胖儿童,分析出生体重与肝损伤严重程度的相关性。结果显示小于胎龄儿(SGA)出生独立增加严重脂肪变性(OR 4.0,95%CI 1.43-10.9,P=0.008)和NAFLD活动评分(NAS)≥5(OR 2.98,95%CI 1.06-8.33,P=0.037)的可能性。
要点
- SGA出生使儿童NAFLD严重脂肪变性风险增加约4倍(OR 4.0,95%CI 1.43-10.9,P=0.008)。
- SGA出生使NAS≥5风险增加约3倍(OR 2.98,95%CI 1.06-8.33,P=0.037),独立于胰岛素抵抗和PNPLA3基因型。
- PNPLA3-CC野生型是无显著纤维化的最强独立预测因子(OR 0.26,95%CI 0.13-0.52,P<0.001)。
核心结论
- 在NAFLD儿童中,SGA出生增加严重脂肪变性风险,独立于且叠加于胰岛素抵抗和PNPLA3基因I148M变异等其他强危险因素。
研究设计与样本
- 研究纳入288例连续的白种人意大利超重/肥胖儿童,均为经活检证实的NAFLD,分析出生体重与组织学特征、代谢改变、胰岛素抵抗及PNPLA3基因I148M多态性的关联。
主要发现
- 整个NAFLD队列中,12.2%为SGA,62.8%为适于胎龄儿(AGA),25%为大于胎龄儿(LGA)。
- SGA儿童严重脂肪变性(69%)和严重门管区炎症(14%)的患病率高于AGA和LGA组。
- 严重脂肪变性(>66%)的患病率从SGA到AGA到LGA递减,而中度脂肪变性(33-66%)在三组间相似。
- 1型NAFLD患病率在LGA组高于其他两组(25% vs. 5.2% vs. 9.4%),SGA组重叠型患病率(85.8%)高于LGA组(51.4%),但与AGA组(75%)相比无显著差异。
- 多变量回归分析显示,SGA出生使严重脂肪变性可能性增加4倍(OR 4.0,95%CI 1.43-10.9,P=0.008),使NAS≥5可能性增加约3倍(OR 2.98,95%CI 1.06-8.33,P=0.037),独立于稳态模型评估的胰岛素抵抗和PNPLA3基因型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Small for gestational age (SGA) is associated with an increased risk of non-alcoholic fatty liver disease (NAFLD). Our aim was to investigate the correlation of birthweight with the severity of liver damage in a large cohort of children with NAFLD. METHODS: Two hundred and eighty-eight consecutive Caucasian Italian overweight/obese children with biopsy-proven NAFLD were included in the study. We examined the relative association of each histological feature of NAFLD with metabolic alterations, insulin-resistance, I148M polymorphism in the patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene, and birthweight relative to gestational age. RESULTS: In the whole NAFLD cohort, 12.2% of patients were SGA, 62.8% appropriate for gestational age (AGA), and 25% large for gestational age (LGA). SGA children had a higher prevalence of severe steatosis (69%) and severe portal inflammation (14%) compared with the AGA and LGA groups. Notably, severe steatosis (>66%) was decreasing from SGA to AGA and LGA, whereas the prevalence of moderate steatosis (33-66%) was similar in three groups. The prevalence of type 1 NAFLD is higher in the LGA group with respect to the other two groups (25% vs.5.2% vs.9.4%), whereas the SGA group shows a higher prevalence of overlap type (85.8%) with respect to the LGA group (51.4%) but not compared with the AGA group (75%). At multivariable regression analysis, SGA at birth increased fourfold the likelihood of severe steatosis (odds ratio (OR) 4.0, 95% confidence interval (CI) 1.43-10.9, P=0.008) and threefold the likelihood of NAFLD Activity Score (NAS)≥5 (OR 2.98, 95% CI 1.06-8.33, P=0.037) independently of homeostasis model assessment of insulin resistance and PNPLA3 genotype. The PNPLA3-CC wild-type genotype was the strongest independent predictor of the absence of significant fibrosis (OR 0.26, 95% CI 0.13-0.52, P=<0.001). CONCLUSIONS: In children with NAFLD, the risk of severe steatosis is increased by SGA at birth, independent of and in addition to other powerful risk factors (insulin-resistance and I148M variant of the PNPLA3 gene).
引用
- Bugianesi E, Bizzarri C, Rosso C, et al. Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol. 2017. PMID: 28555633. doi:10.1038/ajg.2017.140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。